![1]()
News
Rivaroxaban for stroke prevention after embolic stroke
November 21, 2018
Does rivaroxaban prevent recurrent ischemic stroke in patients with embolic stroke from undetermined source?
![1]()
News
Nasal glucagon ‘viable alternative’ to intramuscular administration
November 20, 2018
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
News
All patients with VTE have a high risk of recurrence
November 20, 2018
Researchers suggest rethinking categorization of patients with incident venous thromboembolism.
![1]()
News
Beware bacteremia suspicious of colon cancer
November 20, 2018
Is bacteremia from certain microbes associated with colorectal cancer?
![1]()
News
Invasive strategy increased bleeding risk in frail older AMI patients
November 19, 2018
Registry analysis suggests frailty in an AMI patient calls for personalized decision making.
![1]()
News
In the Literature – Short Takes
November 19, 2018
Sepsis Campaign bundles shortened to 1 hourIn response to the 2016 Surviving Sepsis Campaign guidelines, the 3-hour and 6-hour bundles have been combined and shortened into a 1-hour bundle to...
News
Consider omitting CSF testing in older, low-risk febrile infants
November 17, 2018
To confirm the safety of omitting CSF testing in low-risk febrile infants older than 28 days, a prospective study will be needed.
![1]()
News
How do hospital medicine groups deal with staffing shortages?
November 16, 2018
The expanding and dynamic labor market for hospitalists has a challenging side for hospitals.
![1]()
News
Procalcitonin testing does not decrease antibiotic use for LRTIs
November 16, 2018
Does testing procalcitonin for lower respiratory tract infections (LRTIs) decrease total antibiotic days without a resultant increase in adverse events?
![1]()
News
Resuming DOAC therapy in AF patients after gastrointestinal bleed
November 15, 2018
For patients who develop a gastrointestinal bleed (GIB) while using direct oral anticoagulant (DOAC) therapy for atrial fibrillation (AF), does the risk of venous thromboembolism (VTE) or recurrent GIB increase after DOAC resumption?
